{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:28:16Z","timestamp":1790742496298,"version":"4.1.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1097\/hjh.0b013e32833b558c","type":"journal-article","created":{"date-parts":[[2010,7,7]],"date-time":"2010-07-07T07:54:07Z","timestamp":1278489247000},"page":"1666-1675","source":"Crossref","is-referenced-by-count":92,"title":["Nitric oxide-independent stimulation of soluble guanylate cyclase reduces organ damage in experimental low-renin and high-renin models"],"prefix":"10.1097","volume":"28","author":[{"given":"Yuliya","family":"Sharkovska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Kalk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Lawrenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Godes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda Sarah","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Wellkisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Geschka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Relle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berthold","family":"Hocher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes-Peter","family":"Stasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210208","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/0002-8703(91)90694-D","article-title":"Resolved and unresolved issues in the prevention and treatment of coronary artery disease: a workshop consensus statement","volume":"121","author":"Dzau","year":"1991","journal-title":"Am Heart J"},{"key":"R2-11-20210208","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrd2038","article-title":"NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential","volume":"5","author":"Evgenov","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"R3-11-20210208","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1183\/09031936.00114407","article-title":"Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension","volume":"32","author":"Schermuly","year":"2008","journal-title":"Eur Respir J"},{"key":"R4-11-20210208","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1177\/0091270008319793","article-title":"Single-dose pharmacokinetics, pharmacodynamics, tolerability, and safety of the soluble guanylate cyclase stimulator BAY 63-2521: an ascending-dose study in healthy male volunteers","volume":"48","author":"Frey","year":"2008","journal-title":"J Clin Pharmacol"},{"key":"R5-11-20210208","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/sj.bjp.0706792","article-title":"NO-independent activation of soluble guanylate cyclase prevents disease progression in rats with 5\/6 nephrectomy","volume":"148","author":"Kalk","year":"2006","journal-title":"Br J Pharmacol"},{"key":"R6-11-20210208","first-page":"R6","article-title":"Transgenic rats with an additional renin gene (TGR(mRen2)27) as a sensitive model for the renal effects of NO Synthase inhibition","volume":"350","author":"Hirth-Dietrich","year":"1994","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"R7-11-20210208","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/0895-7061(96)00195-1","article-title":"Renal and vascular consequences of the chronic nitric oxide synthase inhibition. Effects of antihypertensive drugs","volume":"9","author":"Navarro-Cid","year":"1996","journal-title":"Am J Hypertens"},{"key":"R8-11-20210208","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/cmdc.200900014","article-title":"Discovery of riociguat (BAY 63-2521): a potent, orally active stimulator of soluble guanylate cyclase for the treatment of pulmonary hypertension","volume":"4","author":"Mittendorf","year":"2009","journal-title":"Chem Med Chem"},{"key":"R9-11-20210208","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1161\/01.CIR.103.17.2188","article-title":"Effects of in vivo nitroglycerine treatment on activity and expression of guanylyl cyclase and cGMP-dependent protein kinase and their down-stream target vasodilator-stimulated phosphoprotein in aorta","volume":"103","author":"M\u00fclsch","year":"2001","journal-title":"Circulation"},{"key":"R10-11-20210208","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/sj.bjp.0704484","article-title":"Pharmacological actions of a novel NO-independent guanylyl cyclase stimulator, BAY 41-8543: in vitro studies","volume":"135","author":"Stasch","year":"2002","journal-title":"Br J Pharmacol"},{"key":"R11-11-20210208","first-page":"1967","article-title":"Adjustment of creatinine clearance improve accuracy of Calvert's formula for carboplatin dosing","volume":"67","author":"Ando","year":"1997","journal-title":"Br J Cancer"},{"key":"R12-11-20210208","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/01.hjh.0000166849.72721.1c","article-title":"Systemic cardiovascular disease in uremic rats induced by 1,25(OH)2D3","volume":"23","author":"Haffner","year":"2005","journal-title":"J Hypertens"},{"key":"R13-11-20210208","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/CIRCULATIONAHA.105.581405","article-title":"Activation of soluble guanylate cyclase reverses lung vascular remodelling and pulmonary hypertension evoked by hypoxia in mice","volume":"113","author":"Dumitrascu","year":"2006","journal-title":"Circulation"},{"key":"R14-11-20210208","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/01.fjc.0000210071.54828.9b","article-title":"Protective effects of BAY 41-2272 (sGC stimulator) on hypertension, heart, and cardiomyocyte hypertrophy induced by chronic L-NAME treatment in rats","volume":"47","author":"Zanfolin","year":"2006","journal-title":"J Cardiovasc Pharmacol"},{"key":"R15-11-20210208","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1097\/00004872-200018120-00015","article-title":"ETA receptor blockade induces fibrosis of the clipped kidney in two-kidney-one-clip renovascular hypertensive rats","volume":"18","author":"Hocher","year":"2000","journal-title":"J Hypertens"},{"key":"R17-11-20210208","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1183\/09031936.00039808","article-title":"First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension","volume":"33","author":"Grimminger","year":"2009","journal-title":"Eur Respir J"},{"issue":"Suppl 1","key":"R18-11-20210208","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1186\/1471-2210-9-S1-S14","article-title":"Riociguat dose titration in patients with chronic thromboembolic pulmonary hypertension (CTEPH) or pulmonary arterial hypertension (PAH)","volume":"9","author":"Ghofrani","year":"2009","journal-title":"BMC Pharmacol"},{"key":"R19-11-20210208","doi-asserted-by":"crossref","first-page":"667","DOI":"10.7326\/0003-4819-114-8-667","article-title":"Tolerance to organic nitrates: evidence, mechanisms, clinical relevance, and strategies for prevention","volume":"114","author":"Elkayam","year":"1991","journal-title":"Ann Int Med"},{"key":"R20-11-20210208","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1172\/JCI118935","article-title":"Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase. A new action for an old drug","volume":"98","author":"M\u00fcnzel","year":"1996","journal-title":"J Clin Invest"},{"key":"R21-11-20210208","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/35065611","article-title":"NO-independent regulatory site on soluble guanylate cyclase","volume":"410","author":"Stasch","year":"2001","journal-title":"Nature"},{"key":"R22-11-20210208","doi-asserted-by":"crossref","first-page":"F167","DOI":"10.1152\/ajprenal.00197.2005","article-title":"Enhancing cGMP in experimental progressive renal fibrosis: soluble guanylate cyclase stimulation vs. phosphodiesterase inhibition","volume":"290","author":"Wang","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"R23-11-20210208","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1523-1755.2005.00380.x","article-title":"Stimulation of soluble guanylate cyclase slows progression in antithy1-induced chronic glomerulosclerosis","volume":"68","author":"Wang","year":"2005","journal-title":"Kidney Int"},{"key":"R24-11-20210208","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1172\/JCI119883","article-title":"Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblast","volume":"101","author":"Calderone","year":"1998","journal-title":"J Clin Invest"},{"key":"R25-11-20210208","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.cardiores.2003.12.005","article-title":"Volume overload results in exaggerated cardiac hypertrophy in the atrial natriuretic peptide knockout mouse","volume":"61","author":"Mori","year":"2004","journal-title":"Cardiovasc Res"},{"key":"R26-11-20210208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1527-5299.2004.03271.x","article-title":"BNP Consensus Panel 2004: a clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases","volume":"10","author":"Silver","year":"2004","journal-title":"Congest Heart Fail"},{"key":"R27-11-20210208","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0272-6386(04)00812-1","article-title":"Diagnostic and prognostic value of plasma brain natriuretic peptide in nondialysis-dependent CRF","volume":"44","author":"Takami","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"R28-11-20210208","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1161\/01.CIR.99.16.2185","article-title":"Vascular endothelin-1 gene expression and synthesis and effect on renal type I collagen synthesis and nephroangiosclerosis during nitric oxide synthase inhibition in rats","volume":"99","author":"Tharaux","year":"1999","journal-title":"Circulation"},{"key":"R29-11-20210208","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1073\/pnas.070371497","article-title":"Cardiac fibrosis in mice lacking brain natriuretic peptide","volume":"97","author":"Tamura","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R30-11-20210208","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0008-6363(02)00667-3","article-title":"Antihypertrophic actions of the natriuretic peptides in adult rat cardiomyocytes: importance of cyclic GMP","volume":"57","author":"Rosenkranz","year":"2003","journal-title":"Cardiovasc Res"},{"key":"R31-11-20210208","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/hr.2009.64","article-title":"Pressure-independent effects of pharmacological stimulation of soluble guanylate cyclase on fibrosis in pressure-overloaded rat heart.","volume":"32","author":"Masuyama","year":"2009","journal-title":"Hypertens Res"}],"container-title":["Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HJH.0b013e32833b558c","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T23:46:47Z","timestamp":1685663207000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004872-201008000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/hjh.0b013e32833b558c","relation":{},"ISSN":["0263-6352"],"issn-type":[{"value":"0263-6352","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}